Cure Model Survival Analysis After Hepatic Resection for Colorectal Liver Metastases
- 802 Downloads
Statistical cure is achieved when a patient population has the same mortality as cancer-free individuals; however, data regarding the probability of cure after hepatectomy of colorectal liver metastases (CLM) have never been provided. We aimed to assess the probability of being statistically cured from CLM by hepatic resection.
Data from 1,012 consecutive patients undergoing curative resection for CLM (2001–2012) were used to fit a nonmixture cure model to compare mortality after surgery to that expected for the general population matched by sex and age.
The 5- and 10-year disease-free survival was 18.9 and 15.8 %; the corresponding overall survival was 44.3 and 32.7 %. In the entire study population, the probability of being cured from CLM was 20 % (95 % confidence interval 16.5–23.5). After the first year, the mortality excess of resected patients, in comparison to the general population, starts to decline until it approaches zero 6 years after surgery. After 6.48 years, patients alive without tumor recurrence can be considered cured with 99 % certainty. Multivariate analysis showed that cure probabilities range from 40.9 % in patients with node-negative primary tumors and metachronous presentation of a single lesion <3 cm, to 1.5 % in patients with node positivity, and synchronous presentation of multiple, large CLMs. A model for the calculation of a cure fraction for each possible clinical scenario is provided.
Using a cure model, the present results indicate that statistical cure of CLM is possible after hepatectomy; providing this information can help clinicians give more precise answer to patients’ questions.
KeywordsHepatic Resection Colorectal Liver Metastasis Future Remnant Liver Entire Study Population Future Remnant Liver Volume
This work is dedicated to the memory of Prof. Lorenzo Capussotti.
The authors declare no conflict of interest.
- 2.US Cancer Statistics Working Group. United States cancer statistics: 1999–2010 incidence and mortality Web-based report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2013. Available at: http://www.cdc.gov/uscs. Accessed 1 Feb 2014.
- 3.Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55(Suppl 3):iii1–8.Google Scholar
- 6.Statistical Methodology and Applications Branch, Data Modeling Branch, National Cancer Institute. Cansurv, version 1.1. Available at: http://surveillance.cancer.gov/cansurv/index.html. Accessed 1 Feb 2014.
- 9.Terminology Committee of the IHPBA. The Brisbane 2000 terminology of liver anatomy and resections. Abingdon: Taylor & Francis; 2000. p. 333–9.Google Scholar
- 11.Fuller AF, Griffiths CT. Gynecologic oncology. Amsterdam: Wolters Kluwer; 1983.Google Scholar
- 12.Lambert PC. Modeling of the cure fraction in survival studies. Stata J. 2007;3:1–25.Google Scholar
- 14.Italian population life tables. Available at: http://demo.istat.it/. Accessed 1 Dec 2013.
- 18.Dal Maso L, Guzzinati S, Buzzoni C, et al. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818,902 Italian patients and 26 cancer types. Ann Oncol. 2014;25:2251-60.Google Scholar
- 19.Viganò L, Capussotti L, Lapointe R, et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276–1286.Google Scholar